Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Placebo-controlled, Cross-over Study of the Safety and Immunogenicity of Trivalent, Inactivated Influenza Vaccine for 2010-2011

NCT01140009 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01140009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01140009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Placebo-controlled, Cross-over Study of the Safety and Immunogenicity of Trivalent, Inactivated Influenza Vaccine for 2010-2011
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
September 30, 2010
Enrollment
324 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza